"10.1371_journal.pone.0042657","plos one","2012-09-10T00:00:00Z","Beat Nyfeler; Dominic Hoepfner; Deborah Palestrant; Christina A Kirby; Lewis Whitehead; Robert Yu; Gejing Deng; Ruth E Caughlan; Angela L Woods; Adriana K Jones; S Whitney Barnes; John R Walker; Swann Gaulis; Ervan Hauy; Saskia M Brachmann; Philipp Krastel; Christian Studer; Ralph Riedl; David Estoppey; Thomas Aust; N Rao Movva; Zuncai Wang; Michael Salcius; Gregory A Michaud; Gregory McAllister; Leon O Murphy; John A Tallarico; Christopher J Wilson; Charles R Dean","Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Cambridge, Massachussetts, United States of America; Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Basel, Switzerland; Center for Proteomic Chemistry, Novartis Institutes for BioMedical Research, Cambridge, Massachussetts, United States of America; Infectious Diseases, Novartis Institutes for BioMedical Research, Emeryville, California, United States of America; Novartis Institute for Functional Genomics, Novartis Institutes for Biomedical Research, San Diego, California, United States of America; Disease Area Oncology, Novartis Institutes for BioMedical Research, Basel, Switzerland; Center for Proteomic Chemistry, Natural Products Unit, Novartis Institutes for BioMedical Research, Basel, Switzerland; Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Cambridge, Massachussetts, United States of America","Conceived and designed the experiments: CRD BN DH DP CK GD. Performed the experiments: REC ALW AKJ SWB RY CS RR TA DE BN ZW MS EH. Analyzed the data: CRD BN DH SWB LW JRW GAM GM LOM CJW SG SMB JT NRM. Contributed reagents/materials/analysis tools: PK. Wrote the paper: CD BN DH CK.","The authors are, at present, or were during the time of their contribution to this manuscript, employed by Novartis Pharmaceuticals, under the umbrella of the Novartis Institutes for Biomedical Research (NIBR). As such, the authors all own stock in Novartis as part of their remuneration for employment. There are no competing interests as regards consultancies, patents or products in development or currently marketed. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2012","09","Beat Nyfeler","BN",29,FALSE,6,13,14,4,TRUE,TRUE,FALSE,0,NA,FALSE
